Citation: | WANG Donghao. Progress and Prospect in Intensive Care and Treatment of Patients with Solid Tumors[J]. Cancer Research on Prevention and Treatment, 2023, 50(12): 1149-1152. DOI: 10.3971/j.issn.1000-8578.2023.23.0682 |
The incidence of cancer has remained high in recent years, and anti-tumor treatment methods are emerging. Cancer treatment has undergone significant changes, and the survival rate of patients with cancer has significantly improved. Various types of new anti-tumor treatments may not only treat and control tumor growth but also place patients in critical situations that require treatment by intensive care medical personnel. Patients with cancer are in critical condition mainly due to three reasons: severe cases caused by cancer diseases themselves, complications during the perioperative period, and accompanying diseases and hospital acquired diseases. In the new situation, we should consider patient characteristics, such as abnormal metabolism, abnormal coagulation system, and abnormal immune mechanism, to save them from serious illness. We need to comprehensively evaluate patients with cancer, emphasize the role of the Intensive Care Unit (ICU) treatment platform, and promote the treatment concept of planned transfer to ICU, to improve the success rate and efficiency of treatment. After transferring the patient out of the ICU, the planned follow-up anti-tumor treatment can still be continued as the endpoint of ICU treatment for critically ill patients with cancer. In the future, efforts will be devoted to establishing a discipline and talent echelon with distinctive characteristics of oncology critical care medicine and treating "the critical illness of cancer and the cancer of critical illness".
Competing interests: The author declare that he has no competing interests.
[1] |
ACCCM, SCCCM. Guidelines for intensive care unit admission, discharge, and triage Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine[J]. Crit Care Med, 1999, 27(3): 633-638. doi: 10.1097/00003246-199903000-00048
|
[2] |
郑荣寿, 张思维, 孙可欣, 等. 2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2023, 45(3): 212-220. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202311001.htm
Zheng RS, Zhang SW, Sun KX, et al. Analysis on the Prevalence of Malignant Tumors in China in 2016[J]. Zhonghua Zhong Liu Za Zhi, 2023, 45(3): 212-220. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202311001.htm
|
[3] |
Soares M, Bozza FA, Azevedo LC, et al. Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units[J]. J Clin Oncol, 34(27): 3315-3324. doi: 10.1200/JCO.2016.66.9549
|
[4] |
Soubani AO. Critical Care Prognosis and Outcomes in Patients with Cancer[J]. Clin Chest Med, 2017, 38(2): 333-353. doi: 10.1016/j.ccm.2016.12.011
|
[5] |
Shimabukuro-Vornhagen A, Boll B, Kochanek M, et al. Critical care of patients with cancer[J]. CA Cancer J Clin, 2016, 66(6): 21351.
|
[6] |
Reddy DRS, Botz GH. Triage and Prognostication of Cancer Patients Admitted to the Intensive Care Unit[J]. Crit Care Clin, 2021, 37(1): 1-18. doi: 10.1016/j.ccc.2020.08.001
|
[7] |
Quinn TD, Gabriel RA, Dutton RP, et al. Analysis of Unplanned Postoperative Admissions to the Intensive Care Unit[J]. J Intensive Care Med, 2017, 32(7): 436-443. doi: 10.1177/0885066615622124
|
[8] |
Wang Y, Cui K, Li X, et al. Current census of oncology critical care medicine in China[J]. QJM, 2022, 115(11): 745-752. doi: 10.1093/qjmed/hcac104
|